These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35292876)

  • 1. Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report.
    Kihara M; Miyauchi A; Hirokawa M; Fujishima M; Masuoka H; Higashiyama T; Onoda N; Ito Y; Miya A
    Surg Case Rep; 2022 Mar; 8(1):45. PubMed ID: 35292876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of Serum Levels of Carbohydrate Antigen 19-9 (CA19-9) as a Surrogate Tumor Marker for Papillary Thyroid Carcinoma.
    Kihara M; Miyauchi A; Hirokawa M; Suzuki A; Akamizu T
    JMA J; 2024 Apr; 7(2):250-257. PubMed ID: 38721086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy.
    Yamada O; Miyauchi A; Ito Y; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Endocr J; 2014; 61(10):961-5. PubMed ID: 25029954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
    Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
    Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
    Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
    J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
    Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
    Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA19-9 producing locally advanced papillary thyroid carcinoma: a case report.
    Morikawa H; Oba T; Kitazawa A; Iji R; Kiyosawa N; Amitani M; Shimizu T; Kanai T; Uehara T; Ito KI
    Surg Case Rep; 2024 Apr; 10(1):83. PubMed ID: 38598167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
    Hsieh CJ; Wang PW
    Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of
    Qiu ZL; Wei WJ; Shen CT; Song HJ; Zhang XY; Sun ZK; Luo QY
    Sci Rep; 2017 Jun; 7(1):2849. PubMed ID: 28588229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROGNOSIS OF HIGH-RISK PAPILLARY THYROID CANCER PATIENTS WITH PRE-ABLATION STIMULATED TG <1 NG/ML.
    Tian T; Kou Y; Huang R; Liu B
    Endocr Pract; 2019 Mar; 25(3):220-225. PubMed ID: 30913010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary liver metastasis from follicular variant papillary thyroid carcinoma: A case report and literature review.
    Djenic B; Duick D; Newell JO; Demeure MJ
    Int J Surg Case Rep; 2015; 6C():146-9. PubMed ID: 25536153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin as a Rapid and Cost-Effective Biomarker for Diagnosis of Thyroid Carcinoma Brain Metastasis: A Case Report of a Patient with Metastatic Hurthle Cell Thyroid Carcinoma.
    Ntotsikas K; Lazarioti S; Daraki V; Drakos E; Tsakalomatis PN; Syntzanaki EK; Moustakis N; Marinis AI; Salapatas-Gkinis A; Xekouki P; Vakis A; Tsitsipanis C
    Am J Case Rep; 2023 Oct; 24():e939025. PubMed ID: 37853680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver metastasis from papillary thyroid carcinoma treated by laparoscopic hepatectomy 43 years after resection of the primary tumor: a case report.
    Tsukagoshi M; Harimoto N; Araki K; Kubo N; Watanabe A; Igarashi T; Ishii N; Yajima T; Sano T; Shirabe K
    Surg Case Rep; 2020 Jun; 6(1):142. PubMed ID: 32556940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
    Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
    Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
    Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators.
    Qiu ZL; Shen CT; Sun ZK; Song HJ; Zhang GQ; Luo QY
    Front Endocrinol (Lausanne); 2019; 10():903. PubMed ID: 31998236
    [No Abstract]   [Full Text] [Related]  

  • 20. CA19-9-producing lung metastasis after surgery for papillary thyroid carcinoma: report of a case.
    Yamaguchi E; Makino Y; Sato T; Uchida M; Harada Y; Maruyama R
    Surg Today; 2014 Nov; 44(11):2157-61. PubMed ID: 24407283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.